Top compounds associated with response to ZNF829


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib GDSC1000 pan-cancer AAC 0.08 0.02
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC 0.14 0.02
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.02
mRNA BRD-K71935468 CTRPv2 pan-cancer AAC 0.095 0.02
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC -0.088 0.02
mRNA TL-1-85 GDSC1000 pan-cancer AAC 0.069 0.02
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.02
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.09 0.02
mRNA Crizotinib gCSI pan-cancer AAC -0.15 0.02
mRNA TG-101348 GDSC1000 pan-cancer AAC 0.064 0.02
Download CSV